Thursday, January 26, 2017 5:31:11 PM
Co-Founder, Chief Regulation officer (CRO)
Miri. Sani has more than 20 years of experience in the Israeli Biotech industry, working as VP of regulatory affairs with several Israeli and international companies. Nowadays, and for the last several years, Ms. Sani serves as CEO of her regulatory consulting company, working with multiple start-up companies. She brings to LBT a wide range of multi-disciplinary knowledge, developed over the years while serving the medical device and pharmaceutical and biotech industry as an expert advisor in large and small companies.
http://www.lbtpharma.com/Management.html
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM